Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ZoneOne Pharma

ZoneOne Pharma?uq=3Oe4kK1Z
2011 FOUNDED
PRIVATE STATUS
Grant LATEST DEAL TYPE
$994K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of nano-scale therapeutics. The company develops liposomal chelator therapeutics and contract formulation of liposome drugs.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Biotechnology
Drug Discovery
Primary Office
  • QB3 Byers Hall, 1700 4th Street
  • Suite 214
  • San Francisco, CA 94158
  • United States

+1 (415) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ZoneOne Pharma’s full profile, request a free trial.

ZoneOne Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-May-2015 $994K Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ZoneOne Pharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0

ZoneOne Pharma Executive Team (3)

Name Title Board
Seat
Contact
Info
Charles Noble Ph.D President & Founding Scientist
Peter Working Ph.D Co-Founder & Director of Regulatory Affairs
Mark Hayes Ph.D Co-Founder & Senior Scientist

ZoneOne Pharma Board Members (1)

Name Representing Role Since Contact
Info
J.P. Michael Motion Ph.D ZoneOne Pharma Board Member 000 0000